Marked Response to Lu-177 Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer

SOYDAL Ç., ÖZKAN E., AKYÜREK S., KÜÇÜK N. Ö.

CLINICAL NUCLEAR MEDICINE, cilt.41, sa.2, ss.159-160, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 41 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1097/rlu.0000000000001058
  • Dergi Adı: CLINICAL NUCLEAR MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.159-160
  • Anahtar Kelimeler: Ga-68-PSMA PET/CT, Lu-177-PSMA treatment, prostatic cancer, INHIBITOR
  • Ankara Üniversitesi Adresli: Evet

Özet

We present pretreatment Ga-68 prostate-specific membrane antigen (PSMA) PET/CT and posttreatment Lu-177-PSMA whole-body scintigraphy images of a 60-year-old patient with metastatic prostate cancer who is dramatically responding to Lu-177-PSMA treatment.